Yield of stool culture with isolate toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile

被引:121
作者
Reller, Megan E.
Lema, Clara A.
Perl, Trish M.
Cai, Mian
Ross, Tracy L.
Speck, Kathleen A.
Carroll, Karen C.
机构
[1] Johns Hopkins Med Inst, Dept Pathol, Div Med Microbiol, Baltimore, MD 21287 USA
[2] Johns Hopkins Med Inst, Dept Hosp Epidemiol & Infect Control, Baltimore, MD 21205 USA
关键词
D O I
10.1128/JCM.01305-07
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We examined the incremental yield of stool culture (with toxin testing on isolates) versus our two-step algorithm for optimal detection of toxigenic Clostridium difficile. Per the two-step algorithm, stools were screened for C. difficile-associated glutamate dehydrogenase (GDH) antigen and, if positive, tested for toxin by a direct (stool) cell culture cytotoxicity neutralization assay (CCNA). In parallel, stools were cultured for C. difficile and tested for toxin by both indirect (isolate) CCNA and conventional PCR if the direct CCNA was negative. The "gold standard" for toxigenic C. difficile was detection of C. difficile by the GDH screen or by culture and toxin production by direct or indirect CCNA. We tested 439 specimens from 439 patients. GDH screening detected all culture-positive specimens. The sensitivity of the two-step algorithm was 77% (95% confidence interval [CI], 70 to 84%), and that of culture was 87% (95% CI, 80 to 92%). PCR results correlated completely with those of CCNA testing on isolates (29/29 positive and 32/32 negative, respectively). We conclude that GDH is an excellent screening test and that culture with isolate CCNA testing detects an additional 23% of toxigenic C. difficile missed by direct CCNA. Since culture is tedious and also detects nontoxigenic C. difficile, we conclude that culture is most useful (i) when the direct CCNA is negative but a high clinical suspicion of toxigenic C. difficile remains, (ii) in the evaluation of new diagnostic tests for toxigenic C. difficile (where the best reference standard is essential), and (iii) in epidemiologic studies (where the availability of an isolate allows for strain typing and antimicrobial susceptibility testing).
引用
收藏
页码:3601 / 3605
页数:5
相关论文
共 38 条
[1]   Comparison of the TOX A/B test to a cell culture cytotoxicity assay for the detection of Clostridium difficile in stools [J].
Aldeen, WE ;
Bingham, M ;
Aiderzada, A ;
Kucera, J ;
Jense, S ;
Carroll, KC .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2000, 36 (04) :211-213
[2]   Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains [J].
Barbut, F ;
Decré, D ;
Lalande, V ;
Burghoffer, A ;
Noussair, L ;
Gigandon, A ;
Espinasse, F ;
Raskine, L ;
Robert, J ;
Mangeol, A ;
Branger, C ;
Petit, JC .
JOURNAL OF MEDICAL MICROBIOLOGY, 2005, 54 (02) :181-185
[3]   NUCLEOTIDE-SEQUENCE OF CLOSTRIDIUM-DIFFICILE TOXIN-B GENE [J].
BARROSO, LA ;
WANG, SZ ;
PHELPS, CJ ;
JOHNSON, JL ;
WILKINS, TD .
NUCLEIC ACIDS RESEARCH, 1990, 18 (13) :4004-4004
[4]   Narrative review: The new epidemic of clostridium difficile-associated enteric disease [J].
Bartlett, John G. .
ANNALS OF INTERNAL MEDICINE, 2006, 145 (10) :758-764
[5]   Immunological detection and cytotoxic properties of toxins from toxin A-positive, toxin B-positive Clostridium difficile variants [J].
Blake, JE ;
Mitsikosta, F ;
Metcalfe, MA .
JOURNAL OF MEDICAL MICROBIOLOGY, 2004, 53 (03) :197-205
[6]   USEFULNESS OF CULTURE IN THE DIAGNOSIS OF CLOSTRIDIUM-DIFFICILE INFECTION [J].
BOND, F ;
PAYNE, G ;
BORRIELLO, SP ;
HUMPHREYS, H .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1995, 14 (03) :223-226
[7]   Frequency of sample submission for optimal utilization of the cell culture cytotoxicity assay for detection of Clostridium difficile toxin [J].
Borek, AP ;
Aird, DZ ;
Carroll, KC .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (06) :2994-2995
[8]   Clinical manifestations, treatment and control of infections caused by Clostridium difficile [J].
Bouza, E ;
Muñoz, P ;
Alonso, R .
CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 :57-64
[9]  
Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P1201
[10]  
CLSI, 2007, METH ANT SUSC TEST A